Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
2/1/26 Pharming (PHAR) Joenja for Activated PI3K Delta Syndrome (APDS) Subscribers Only Subscribers Only Subscribers Only
1/29/26 Delta-Fly (4598) DFP-10917 for Acute Myelogenous Leukemia (AML) Subscribers Only Subscribers Only Subscribers Only
1/27/26 Sarepta Therapeutics (SRPT) Elevidys for Duchenne Muscular Dystrophy (DMD) Subscribers Only Subscribers Only Subscribers Only
1/23/26 Trevi (TRVI) Haduvio for Chronic Cough Subscribers Only Subscribers Only Subscribers Only
1/22/26 IntraBio Aqneursa for Ataxia Telangiectasia Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/08/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/17/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update